medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2009, Number 4

<< Back Next >>

Arch Neurocien 2009; 14 (4)

Impact medical, social and economic insomnia

Reyes LA, Lemus CA, Manterola CO, Ramírez BJ

Language: Spanish
References: 70
Page: 266-272
PDF size: 138.89 Kb.


ABSTRACT

Insomnia is an entity that is present in almost all age groups, but when age advances it becomes more frequent. Published prevalence estimations of insomnia widely change in accordance with the different definitions used. There have been found statistically significant associations between insomnia and a hostof somatic and mental diseases, and controversy exists regarding the causal relationship between insomnia and depression. Indirect costs of insomnia exceed so far the direct medical costs, however similar as with the prevalence rates, these estimations also suffer from methodological problems that make them controversial. The impact of insomnia in the workplace is important, while the most effective treatment options can bé combined for improve the results.


REFERENCES

  1. Suárez-Rodríguez A, Robles-García B. Hábitos de sueño en la revisión del niño sano. Bol Pediatr 2005; 45:17-22.

  2. Levy D, Gray-Donald K, Leech J. Sleep patterns and problems in adolescents. J Adolesc Heath Care 1986; 7:386-9.

  3. Kirmil-Gray K, Eaglestone JR, Gibson E. Sleep disturbance in adolescents: sleep quality, sleep habits, beliefs about sleep, and daytime functioning. J Youth Adolesc 1984; 13:375-84.

  4. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989; 262:1479-84.

  5. Ohayon MM, Caulet M, Lemoine P. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry. 1998; 39:185-97.

  6. Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J Psychosom Res. 2001; 51:745-55.

  7. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999; 22(suppl 2):S347-53.

  8. Ishigooka J, Suzuki M, Isawa S, Muraoka H, Murasaki M,Okawa M. Epidemiological study of sleep habits and insomnia of new outpatients visiting general hospitals in Japan. Psychiatry Clin Neurosci. 1999; 53:515-22.

  9. Simon GE, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997;154:1417-23.

  10. Yeo BK, Perera IS, Kok LP. Insomnia in the community. Singapore Med J 1996; 37:282-4.

  11. Janson C, Norbáck D, Omenaas E, Gislason T, Nystróm E, Jeigi R, et al. Insomnia is more common among subjects living in damp buildings. Occup Environ Med 2005; 62:113-8.

  12. Trujillo de los Santos, Z. Insomnio en el paciente geriátrico. Arch Neurocien (Mex) 1997; 2:122-7.

  13. Pando-Moreno M, Aranda-Beltran C, Aguilar-Aldrete ME, Mendoza-Roaf PL, Salazar-Estrada J. Prevalencia de los trastornos del sueño en el adulto mayor. Cad Saúde Pública, Rio de Janeiro 2001; 17(1):63-9.

  14. Husby R, Lingjaerde O. Prevalence of reported sleeplessness in northern Norway in relation to sex, age and season. Acta Psychiatr Scand 1990; 81:542-7.

  15. Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997; 47:166-9.

  16. Li RHY, Wing YK, Ho SC. Gender differences in insomnia -a study in the Hong Kong Chinese population. J Psychosom Res 2002; 53:601-9.

  17. Reyner LA, Horne JA, Reyner A. Gender and age-related differences in sleep determined by honre recorded sleep logs and actimetry from 400 adults. Sleep 1995; 18:127-34.

  18. Rey de Castro J, Vizcarra D. Frecuencia de síntomas del síndrome apnea hipopnea del sueño e insomnio en médicos de una clínica privada peruana. Rev Med Hered 2003;14:53-8.

  19. Francisco-Baez G, Flores-Correa N, González-Sandoval T, Horrisberger H. Calidad del sueño en estudiantes de medicina. Rev Pos VI Cátedra Med 2005; 141:14-7.

  20. Durand G, Rey de Castro J. Hábitos y trastornos del sueño en rotadores de turnos de trabajo en una fábrica de bebidas. An Fac Med Univ Nac S Marcos 2004; 65:97-102.

  21. Geroldi C, Frisoni GB, Rozzini R, De Leo D, Trabucchi M. Principal lifetime occupation and sleep quality in the elderly. Gerontology 1996; 42:163-9.

  22. Pacheco-Quesada GM, Rey-De-Castro MJ. Insomnio en pacientes adultos ambulatorios de medicina interna del Hospital Nacional Arzobispo Loayza. Rev Med Hered 2003; 14:63-8.

  23. Arias-Congrains J. Omisión en el registro de insomnio en pacientes internados en un hospital general. Rev Med Hered 2003; 14:59-62.

  24. Rey-De-Castro Mi, Álvarez-Mayorga J, Gaffo A. Síntomas relacionados a trastornos del sueño en supuestos sanos que asisten a un centro de Atención Primaria de Salud. Rey Med Hered 2005; 16:31-8.

  25. Alvarado R. Frecuencia del insomnio en México. Arch Neurocien (Mex) 1997; 2:114-21.

  26. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry 2001; 62 (suppl 10):33-8.

  27. Neubauer DN. Chronic insomnia: current issues. Clin Cornerstone 2004; 6 (Suppl 1C):S17-S22.

  28. Ancoli-Israel S. The impact and prevalence of chronic insomniaand other sleep disturbances associated with chronic illness. Am J Manag Care 2006; 12:S221-S9.

  29. Katz DA, McHornery CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998; 158:1099- 107.

  30. Gislason T, Reynisdottir H, Kristbjarnarson H. Sleep habits and sleep disturbances among the elderly-an epidemiological survey. J Int Med 1993; 234(1):31-9.

  31. Leppavuori A, Pohjasvaara T, Vataja R. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002; 14(2):90-7.

  32. Foley DJ, Monjan A, Simonsick EM. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999;22(Suppl 2):S366-72.

  33. Bliwise DL. Sleep disorders in Alzheimer’s disease and other dementias. Clin Cornerstone 2004; 6(suppl 1A):S16-S28.

  34. Thorpy MJ. Sleep disorders in Parkinson’s disease. Clin Cornerstone. 2004; 6(suppl 1A):S7-S15.

  35. Benca RM, Obermeyer WH, Thisted RA, Guillin JC. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 1992; 49:651-68.

  36. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry 1996; 39:411-8.

  37. Chang PP, Ford DE, Mead LA. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997; 146:105-14.

  38. Morawetz D. Insomnia and depression: Which comes first? Sleep Res Online 2003; 5(2):77-81.

  39. Gillin JC. Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand Suppl 1998; 98:39-43.

  40. Chilcott LA, Shapiro CM. The socioeconomic impact ofinsomnia – an overview. Pharmacoeconomics 1996; 10:1-14.

  41. Dement WC, Mitler MM. It’s time to wake up to the importanceof sleep disorders. JAMA 1993; 269:1548-9.

  42. National Institutes of Health. State-of-the-Science ConferenceStatement on Manifestations and Management of Chronic Insomnia in Adults; June 13-15,2005. Sleep 2005;28:1049-57.

  43. Walsh J, Engelhardt C. The direct economic costs of insomnia in the United States for 1995. Sleep 1999; 22(Suppl 2):S386-3.

  44. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep 1999; 22(Suppl 2): S394-S401.

  45. Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16(5): 873-97.

  46. Martin SA, Aiken JE, Chervin RD. Toward cost-effectiveness analysis in the diagnosis and treatment of insomnia. Sleep Med Rev 2004; 8:63-72.

  47. González-Silva M. Enfermedades del sueño y su impacto laboral. Cien Trab 2004; 6(12):48-52.

  48. Metlaine A, Leger D, Choudat D. Socioeconomic impact of insomnia in working populations. Industr Health 2005;43:11-9.

  49. Leigh JP. Employee and job attributes as predictors of absenteeism in a national sample of workers: the importance of health and dangerous conditions. Soc Sci Med 1991;33: 127-37.

  50. Akerstedt T, Fredlund P, Gillberg M, Jansson B. A prospective study of fatal occupational accidents-relationship to sleeping difficulties and occupational factors. J Sleep Res 2002;11:69-71.

  51. Léger D, Guillemenault C, Bader G, Levy E, Paillard M. Medical and socioprofesional impact of insomnia. Sleep 2002;25:625-9.

  52. Fullerton P. The economic impact of insomnia in managed care: a clearer picture emerges. Am J Manag Care 2006; 12:S246-S52.

  53. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, andcoping skills in primary insomnia. Psych Med 2003;65:259-67.

  54. Contreras G, Córdova V. Controversias sobre sueño y trabajo. Ciencia & Trab 2004; 6(12):70-2.

  55. Sivertsen B, Overland S, Neckelmann D, Glozier N, Krokstad S, Pallesen S, et al. The Long-term Effect of Insomnia on Work Disability. The HUNT-2 Historical Cohort Study. Am J Epidemiol 2006; 163:1018-24.

  56. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999; 22:S379- S85.

  57. Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: Evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med 2001;63:49-55.

  58. Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract 2002; 51:229-35.

  59. Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 1999; 22(Suppl 2):S354-8.

  60. Jiménez-Genchi A, Díaz-Ceballos MA. El insomnio en la práctica médica. Rey Fac Med UNAM 2000; 43(2):46-8.

  61. Organización Panamericana de la Salud. Insomnio. Guía de diagnóstico y manejo. Disponible en: http://www.s1d.cuiga lerias/pdf/sitiosigericuba/guía23.pdf

  62. Drake CL, Roehrs T, Roth T. insomnia causes, consequences, and therapeutics: an overview. Depres Anxiety 2003;18:163-76.

  63. Hoehns JD, Perry PJ. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia. Clin Pharm 1993;12:814-28.

  64. Darcourt G, Pringuey D, Salliére D, Lavoisy J. The safety and tolerability of zolpidem -an update. J of Psychopharm 1999;13 (1): 81-93 .

  65. Crestani F, Martin JR, Mdhler H, Rudolph U. Mechanism of action of the hypnotic zolpidem in vivo. Brit J Pharm 2000; 131:1251-4.

  66. Dündar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, et al. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Tech Assess 2004; (8)24.

  67. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharma-cotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159:5-11.

  68. Wang MY, Wang SY, Tsai PS. Cognitive behavioral therapy for primary insomnia: a systematic review. Journal Adv Nurs 2005; 50(5):553-64.

  69. Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the management of long-term hypnotic drug use: a pragmatic randomised controlled trial. Brit J Gen Prac 2003; 53:923-8.

  70. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281:991-9.




2020     |     www.medigraphic.com